Bumper Offer - Urjas oil Just @ Rs. 1
Ramistar 2.5 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. High BP are some of its major therapeutic uses. The alternative uses of Ramistar 2.5 Tablet (15) have also been explained below.
The correct dosage of Ramistar 2.5 Tablet (15) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Ramistar 2.5 Tablet (15) include Confusion. Some other side effects of Ramistar 2.5 Tablet (15) have been listed ahead. Such side effects of Ramistar 2.5 Tablet (15) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Ramistar 2.5 Tablet (15) is Severe for pregnant women and Mild for women who are breastfeeding. In addition, Ramistar 2.5 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Ramistar 2.5 Tablet (15) related warnings section.
Individuals suffering from medical conditions like Angioedema, Heart Failure, Low Blood Pressure (Hypotension) must refrain from the use of Ramistar 2.5 Tablet (15) since this can cause severe adverse effects. Other contraindications of Ramistar 2.5 Tablet (15) have been discussed in the sections ahead.
Besides this, Ramistar 2.5 Tablet (15) may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Ramistar 2.5 Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Ramistar 2.5 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Ramistar 2.5 Tablet (15) is used -
Mild
Common
Is the use of Ramistar 2.5 Tablet (15) safe for pregnant women?
Ramistar should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Ramistar 2.5 Tablet (15) safe during breastfeeding?
Ramistar may have very limited harmful effects for breastfeeding women.
What is the effect of Ramistar 2.5 Tablet (15) on the Kidneys?
Ramistar rarely affects the kidneys.
What is the effect of Ramistar 2.5 Tablet (15) on the Liver?
Ramistar has very mild side effects on the liver.
What is the effect of Ramistar 2.5 Tablet (15) on the Heart?
Ramistar may have mild side effects on the heart. Most people will never see any effect on the heart.
Ramistar 2.5 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramistar 2.5 Tablet (15) unless your doctor advises you to do so -
Is this Ramistar 2.5 Tablet (15) habit forming or addictive?
Ramistar 2.5 Tablet (15) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ramistar 2.5 Tablet (15) can make you feel drowsy.
Is it safe?
Ramistar 2.5 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Ramistar 2.5 Tablet (15) in mental disorders is not effective.
Interaction between Food and Ramistar 2.5 Tablet (15)
Taking Ramistar 2.5 Tablet (15) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ramistar 2.5 Tablet (15)
It is difficult to say anything about the effect of Ramistar 2.5 Tablet (15) and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503